1. A phase 1b study of Selumetinib in combination with Cisplatin and Gemcitabine in advanced or metastatic biliary tract cancer: the ABC-04 study. Issue 1 (December 2016) Authors: Bridgewater, John; Lopes, Andre; Beare, Sandra; Duggan, Marian; Lee, Dymphna; Ricamara, Maravic; McEntee, Delyth; Sukumaran, Ajithkumar; Wasan, Harpreet; Valle, Juan Journal: BMC cancer Issue: Volume 16:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A phase 1b study of Selumetinib in combination with Cisplatin and Gemcitabine in advanced or metastatic biliary tract cancer: the ABC-04 study. Issue 1 (December 2016) Authors: Bridgewater, John; Lopes, Andre; Beare, Sandra; Duggan, Marian; Lee, Dymphna; Ricamara, Maravic; McEntee, Delyth; Sukumaran, Ajithkumar; Wasan, Harpreet; Valle, Juan Journal: BMC cancer Issue: Volume 16:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A Phase Ib Study of NUC‐1031 in Combination with Cisplatin for the First‐Line Treatment of Patients with Advanced Biliary Tract Cancer (ABC‐08). (3rd December 2020) Authors: McNamara, Mairéad G.; Bridgewater, John; Palmer, Daniel H.; Faluyi, Olusola; Wasan, Harpreet; Patel, Alkesh; Ryder, William D.; Barber, Safia; Gnanaranjan, Chathunissa; Ghazaly, Essam; Evans, T.R. Jeff; Valle, Juan W. Journal: Oncologist Issue: Volume 26:Number 4(2021) Page Start: e669 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A review of conventional and drug-eluting chemoembolization in the treatment of colorectal liver metastases: principles and proof. (May 2015) Authors: Liu, David M; Thakor, Avnesh S; Baerlocher, Mark; Alshammari, Mohammed T; Lim, Howard; Kos, Sebastian; Kennedy, Andrew S; Wasan, Harpreet Journal: Future oncology Issue: Volume 11:Number 9(2015) Page Start: 1421 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Addition of ramucirumab or merestinib to standard first-line chemotherapy for locally advanced or metastatic biliary tract cancer: a randomised, double-blind, multicentre, phase 2 study. Issue 10 (October 2021) Authors: Valle, Juan W; Vogel, Arndt; Denlinger, Crystal S; He, Aiwu Ruth; Bai, Li-Yuan; Orlova, Rashida; Van Cutsem, Eric; Adeva, Jorge; Chen, Li-Tzong; Obermannova, Radka; Ettrich, Thomas J; Chen, Jen-Shi; Wasan, Harpreet; Girvan, Allicia C; Zhang, Wei; Liu, Jiangang; Tang, Chunlao; Ebert, Philip J; Agg... Journal: Lancet oncology Issue: Volume 22:Issue 10(2021) Page Start: 1468 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Anti-tumour activity of a first-in-class agent NUC-1031 in patients with advanced cancer: results of a phase I study. Issue 7 (2nd October 2018) Authors: Blagden, Sarah; Rizzuto, Ivana; Suppiah, Puvan; O'Shea, Daniel; Patel, Markand; Spiers, Laura; Sukumaran, Ajithkumar; Bharwani, Nishat; Rockall, Andrea; Gabra, Hani; El-Bahrawy, Mona; Wasan, Harpreet; Leonard, Robert; Habib, Nagy; Ghazaly, Essam Journal: British journal of cancer Issue: Volume 119:Issue 7(2018) Page Start: 815 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study. Issue 5 (May 2019) Authors: Primrose, John N; Fox, Richard P; Palmer, Daniel H; Malik, Hassan Z; Prasad, Raj; Mirza, Darius; Anthony, Alan; Corrie, Pippa; Falk, Stephen; Finch-Jones, Meg; Wasan, Harpreet; Ross, Paul; Wall, Lucy; Wadsley, Jonathan; Evans, Jeff T R; Stocken, Deborah; Praseedom, Raaj; Ma, Yuk Ting; Davidson, B... Journal: Lancet oncology Issue: Volume 20:Issue 5(2019) Page Start: 663 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Capecitabine Versus Active Monitoring in Stable or Responding Metastatic Colorectal Cancer After 16 Weeks of First-Line Therapy: Results of the Randomized FOCUS4-N Trial. Issue 33 (20th November 2021) Authors: Adams, Richard A.; Fisher, David J.; Graham, Janet; Seligmann, Jenny F.; Seymour, Matthew; Kaplan, Richard; Yates, Emma; Parmar, Mahesh; Richman, Susan D.; Quirke, Philip; Butler, Rachel; Brown, Ewan; Collinson, Fiona; Falk, Stephen; Wasan, Harpreet; Shiu, Kai-Keen; Middleton, Gary; Samuel, Lesli... Journal: Journal of clinical oncology Issue: Volume 39:Issue 33(2021) Page Start: 3693 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trial. Issue 8 (August 2015) Authors: Valle, Juan W; Wasan, Harpreet; Lopes, Andre; Backen, Alison C; Palmer, Daniel H; Morris, Karen; Duggan, Marian; Cunningham, David; Anthoney, D Alan; Corrie, Pippa; Madhusudan, Srinivasan; Maraveyas, Anthony; Ross, Paul J; Waters, Justin S; Steward, Will P; Rees, Charlotte; Beare, Sandy; Dive, Ca... Journal: Lancet oncology Issue: Volume 16:Issue 8(2015:Aug.) Page Start: 967 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trial. Issue 8 (August 2015) Authors: Valle, Juan W; Wasan, Harpreet; Lopes, Andre; Backen, Alison C; Palmer, Daniel H; Morris, Karen; Duggan, Marian; Cunningham, David; Anthoney, D Alan; Corrie, Pippa; Madhusudan, Srinivasan; Maraveyas, Anthony; Ross, Paul J; Waters, Justin S; Steward, Will P; Rees, Charlotte; Beare, Sandy; Dive, Ca... Journal: Lancet oncology Issue: Volume 16:Issue 8(2015:Aug.) Page Start: 967 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗